SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-17-000061
Filing Date
2017-11-07
Accepted
2017-11-07 16:31:28
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq32017.htm 10-Q 639936
2 EXHIBIT 31.1 exhibit311q32017.htm EX-31.1 14031
3 EXHIBIT 31.2 exhibit312q32017.htm EX-31.2 14050
4 EXHIBIT 32.1 exhibit321q32017.htm EX-32.1 8148
  Complete submission text file 0001561743-17-000061.txt   3826370

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kin-20170930.xml EX-101.INS 894022
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20170930.xsd EX-101.SCH 25387
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20170930_cal.xml EX-101.CAL 48249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20170930_def.xml EX-101.DEF 135256
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20170930_lab.xml EX-101.LAB 363504
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20170930_pre.xml EX-101.PRE 213872
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 171183777
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1